EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Proteome Sciences's enterprise value is £21.81 Mil.
Proteome Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £5.03 Mil. Therefore, Proteome Sciences's EV-to-Revenue for today is 4.34.
The historical rank and industry rank for Proteome Sciences's EV-to-Revenue or its related term are showing as below:
LSE:PRM'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.46 Med: 5.63 Max: 125.27
Current: 4.34
During the past 13 years, the highest EV-to-Revenue of Proteome Sciences was 125.27. The lowest was 2.46. And the median was 5.63.
LSE:PRM's EV-to-Revenue is ranked worse than 60.89% of 225
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.13
vs LSE:PRM: 4.34
The historical data trend for Proteome Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Proteome Sciences's EV-to-Revenue
For the Diagnostics & Research subindustry, Proteome Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteome Sciences's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Proteome Sciences's EV-to-Revenue falls into.
Proteome Sciences's current Enterprise Value is £21.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteome Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £5.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteome Sciences's share price for today is £0.0351.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteome Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Proteome Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:PRM has been successfully added to your 